All Articles

Cemvita's breakthrough 75,000-liter scale-up turns biodiesel waste into renewable oil, paving the way for a new generation of Sustainable Aviation Fuel.

A new AI can detect Parkinson's progression where the current gold standard fails. In a stunning validation, the study was led by the very scientists who created the old method.

Crescent's largest-ever fund close highlights booming investor appetite for private credit and promises a major capital infusion for the U.S. lower middle market.

New long-term data for UPLIZNA and TAVNEOS show sustained disease control and reduced steroid use, offering a tangible difference for rare disease patients.

With a potential $4 billion on the line, CytomX and Regeneron are building a new class of cancer therapies designed to act like autonomous agents in the body.

LA's cultural phenomenon Happy Ice expands to Downtown Disney, debuting an all-natural menu and innovative desserts. Founder Lemeir Mitchell's journey comes full circle.

The AI boom is hitting a thermal wall. A new solution, born from electric supercar tech, promises to slash energy use and unlock unprecedented power.

TPH Academy's new Chief Growth Officer isn't just a new hire; he's a signal of intent. Steve Sanders brings a playbook for scaling that could reshape the market.

For decades, businesses have relied on robust IBM i systems. But what happens when they fail? A new AI-driven approach aims to prevent catastrophe, not just clean it up.

As autonomous AI enters healthcare, Datavant joins a key consortium to build the safety guardrails, ensuring patient trust and data integrity remain paramount.

With $50M in pre-sales and a Cabot golf course on the horizon, Revelstoke is redefining mountain living. But can it balance luxury growth with community character?

Vanessa Fusco's win as top female roofer isn't just a personal victory. It signals a major shift in a male-dominated industry and a new model for social impact.

Soccer icon Dwayne De Rosario partners with tech platform LINKSPORTS, aiming to dismantle the financial barriers that sideline one in three Canadian kids.

Nirrin Technologies launches TALOS™, a system using novel laser spectroscopy to eliminate dilution and variability, promising a new standard for biomanufacturing.

A Maine edibles brand is launching nationwide, but the real story is its strategic navigation of legal gray areas and its debut at the Food & Wine Classic.

As Prime Medicine prepares for a key investor conference, its next-gen 'search and replace' gene editing technology faces a crucial test. Can it deliver on its promise?

New research reveals high-net-worth investors are abandoning traditional referrals, using AI and digital due diligence to find advisors who truly get them.

A new free tool promises to arm security providers with an attacker's-eye view, but its real impact may be in reshaping the competitive landscape.

The new INYY ETF promises massive income from Intel's volatility. But a look under the hood reveals NAV erosion, capped gains, and a return of your own capital.

Top 20 firm Cherry Bekaert partners with Fieldguide for a massive agentic AI deployment, signaling a major industry shift from point tools to AI-native platforms.